Sst2 Positive Neuroendocrine Neoplasms clinical trials

Explore recruiting sst2 positive neuroendocrine neoplasms clinical trials.

Recruiting sst2 positive neuroendocrine neoplasms studies right now

Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Sst2 Positive Neuroendocrine Neoplasms trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A Phase 1/2 Dose Escalation Study of CRN09682 With an Expansion Phase in Participants with Progressive Metastatic Somatostatin Receptor Type 2 (SST2)-Expressing Neuroendocrine Neoplasms (NENs) and Other SST2-Expressing Solid Tumors

Spain, France, Germany, Italy

Phase I and Phase II (Integrated)- First administration to humans EU CTIS Study details

Sst2 Positive Neuroendocrine Neoplasms trials by city

Sst2 Positive Neuroendocrine Neoplasms in Toronto Sst2 Positive Neuroendocrine Neoplasms in Vancouver Sst2 Positive Neuroendocrine Neoplasms in Montreal Sst2 Positive Neuroendocrine Neoplasms in Calgary Sst2 Positive Neuroendocrine Neoplasms in Edmonton Sst2 Positive Neuroendocrine Neoplasms in Ottawa Sst2 Positive Neuroendocrine Neoplasms in Winnipeg Sst2 Positive Neuroendocrine Neoplasms in Quebec City Sst2 Positive Neuroendocrine Neoplasms in Hamilton Sst2 Positive Neuroendocrine Neoplasms in Kitchener Sst2 Positive Neuroendocrine Neoplasms in London Sst2 Positive Neuroendocrine Neoplasms in Halifax Sst2 Positive Neuroendocrine Neoplasms in New York Sst2 Positive Neuroendocrine Neoplasms in Los Angeles Sst2 Positive Neuroendocrine Neoplasms in Chicago Sst2 Positive Neuroendocrine Neoplasms in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease